Subtopic Deep Dive

← Synthesis and bioactivity of alkaloids

Pharmacological Activities of Harmine
Research Guide

What is Pharmacological Activities of Harmine?

Pharmacological activities of harmine encompass its inhibition of monoamine oxidase and catechol-O-methyltransferase, neuroprotective effects against neurodegenerative diseases, and anticancer mechanisms through kinase modulation and cytotoxicity.

Harmine, a β-carboline alkaloid from Peganum harmala, exhibits diverse bioactivities including enzyme inhibition and antitumor effects, as documented in over 10 key papers with 200+ combined citations. Studies highlight its role in neuroprotection and cancer therapy via in vitro and in vivo models (Javeed et al., 2018; Aryal et al., 2022). Foundational work established COMT inhibition (Yalçın and Bayraktar, 2009).

Curated Papers

Key Challenges

Why It Matters

Harmine serves as a lead compound for Alzheimer's and depression therapies due to monoamine oxidase inhibition and neuroprotection, as shown in plant alkaloid reviews (Aryal et al., 2022, 87 citations). In oncology, its kinase modulation and cytotoxicity target tumor cells, positioning it for anticancer drug development from traditional plants (Tshikhudo et al., 2023; Lamchouri, 2014). Peganum harmala extracts enhance functional foods and pharmaceuticals, balancing bioactivity with toxicity concerns (Sharifi-Rad et al., 2021).

Key Research Challenges

Toxicity and Safety Profiling

Harmine shows potent cytotoxicity alongside antitumor effects, complicating therapeutic dosing (Lamchouri, 2014, 14 citations). Balancing efficacy against high toxicity in Peganum harmala alkaloids requires advanced bioavailability studies. In vivo models reveal narrow therapeutic windows (Doskaliev et al., 2021).

Bioavailability Optimization

Membrane interactions limit harmine's absorption, impacting drug lead potential (Tsuchiya, 2015, 217 citations). Derivatives aim to enhance delivery, but clinical translation lags. Enzyme inhibition efficacy depends on pharmacokinetic improvements (Yalçın and Bayraktar, 2009).

Mechanism Elucidation

Kinase inhibition and neuroprotective pathways need precise mapping for targeted therapies (Lawson et al., 2016, 32 citations). β-carboline anticancer mechanisms involve multiple targets, hindering specificity (Tshikhudo et al., 2023). Molecular modeling refines understanding but lacks comprehensive validation.

Essential Papers

Membrane Interactions of Phytochemicals as Their Molecular Mechanism Applicable to the Discovery of Drug Leads from Plants

Hironori Tsuchiya · 2015 · Molecules · 217 citations

In addition to interacting with functional proteins such as receptors, ion channels, and enzymes, a variety of drugs mechanistically act on membrane lipids to change the physicochemical properties ...

Potential Therapeutic Applications of Plant-Derived Alkaloids against Inflammatory and Neurodegenerative Diseases

Babita Aryal, Bimal Kumar Raut, Salyan Bhattarai et al. · 2022 · Evidence-based Complementary and Alternative Medicine · 87 citations

Alkaloids are a type of natural compound possessing different pharmacological activities. Natural products, including alkaloids, which originate from plants, have emerged as potential protective ag...

Synthesis, biological evaluation and molecular modeling studies of imidazo[1,2- a ]pyridines derivatives as protein kinase inhibitors

Marie Lawson, Jordi Rodrigo, Blandine Baratte et al. · 2016 · European Journal of Medicinal Chemistry · 32 citations

Anticancer Potential of β‐Carboline Alkaloids: An Updated Mechanistic Overview

Phumudzo P. Tshikhudo, Tafadzwanashe Mabhaudhi, Neil A. Koorbanally et al. · 2023 · Chemistry & Biodiversity · 24 citations

Abstract his comprehensive review is designed to evaluate the anticancer properties of β‐carbolines derived from medicinal plants, with the ultimate goal of assessing their suitability and potentia...

<i>Peganum</i> spp.: A Comprehensive Review on Bioactivities and Health‐Enhancing Effects and Their Potential for the Formulation of Functional Foods and Pharmaceutical Drugs

Javad Sharifi‐Rad, Cristina Quispe, Jesús Herrera‐Bravo et al. · 2021 · Oxidative Medicine and Cellular Longevity · 24 citations

The genus Peganum includes four species widely distributed in warm temperate to subtropical regions from the Mediterranean to Mongolia as well as certain regions in America. Among these species, Pe...

Inhibition of catechol-O-methyltransferase (COMT) by some plant-derived alkaloids and phenolics

Dilek Yalçın, Oğuz Bayraktar · 2009 · Journal of Molecular Catalysis B Enzymatic · 23 citations

Comprehensive review of α-carboline alkaloids: Natural products, updated synthesis, and biological activities

Deping Li, Renze Yang, Jun Wu et al. · 2022 · Frontiers in Chemistry · 19 citations

α-carboline (9 H -pyrido[2,3- b ]indole), contains a pyridine ring fused with an indole backbone, is a promising scaffold for medicinal chemistry. In recent decades, accumulating evidence shows tha...

Reading Guide

Foundational Papers

Start with Yalçın and Bayraktar (2009) for COMT inhibition mechanisms and Lamchouri (2014) for antitumor toxicity profiles, establishing core pharmacological baselines.

Recent Advances

Study Aryal et al. (2022, 87 citations) for neuroprotection applications and Tshikhudo et al. (2023) for updated anticancer mechanisms in β-carbolines.

Core Methods

Core techniques include enzyme inhibition assays (IC50 determination), molecular modeling for kinase binding (Lawson et al., 2016), and membrane interaction studies (Tsuchiya, 2015).

How PapersFlow Helps You Research Pharmacological Activities of Harmine

Discover & Search

Research Agent uses searchPapers and exaSearch to query 'harmine pharmacological activities Peganum harmala', retrieving 250M+ OpenAlex papers including Tsuchiya (2015). citationGraph maps connections from Aryal et al. (2022, 87 citations) to foundational COMT inhibition by Yalçın and Bayraktar (2009); findSimilarPapers expands to β-carboline analogs.

Analyze & Verify

Analysis Agent applies readPaperContent to extract kinase inhibition data from Lawson et al. (2016), then verifyResponse with CoVe chain-of-verification flags inconsistencies in toxicity claims from Lamchouri (2014). runPythonAnalysis with pandas plots IC50 values across studies; GRADE grading scores evidence strength for neuroprotection in Aryal et al. (2022).

Synthesize & Write

Synthesis Agent detects gaps in harmine derivative bioavailability using contradiction flagging on Tsuchiya (2015) vs. Javeed et al. (2018), generating exportMermaid diagrams of activity pathways. Writing Agent employs latexEditText for mechanism sections, latexSyncCitations for 10+ references, and latexCompile to produce publication-ready reviews.

Use Cases

"Extract and plot IC50 values for harmine COMT inhibition from papers"

Research Agent → searchPapers('harmine COMT') → Analysis Agent → readPaperContent(Yalçın 2009) + runPythonAnalysis(pandas plot IC50) → matplotlib graph of enzyme kinetics.

"Write LaTeX review on harmine anticancer mechanisms with citations"

Synthesis Agent → gap detection(Tshikhudo 2023) → Writing Agent → latexEditText(draft) → latexSyncCitations(10 papers) → latexCompile(PDF with figures).

"Find GitHub code for harmine molecular modeling simulations"

Research Agent → paperExtractUrls(Lawson 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect(docking scripts) → runPythonAnalysis(reproduce kinase models).

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(50+ harmine papers) → citationGraph → GRADE grading → structured report on activities. DeepScan applies 7-step analysis with CoVe checkpoints to verify neuroprotection claims from Aryal et al. (2022). Theorizer generates hypotheses on harmine derivatives by synthesizing Tshikhudo et al. (2023) mechanisms with toxicity data.

Try Doxa for Pharmacological Activities of Harmine Research

Frequently Asked Questions

What defines pharmacological activities of harmine?

Harmine's activities include MAO and COMT inhibition, neuroprotection, and anticancer effects via kinase modulation, primarily from Peganum harmala (Javeed et al., 2018).

What are key methods for studying harmine bioactivity?

In vitro enzyme assays measure IC50 for COMT/MAO inhibition (Yalçın and Bayraktar, 2009); in vivo models assess antitumor cytotoxicity and neuroprotection (Aryal et al., 2022; Lamchouri, 2014).

What are foundational papers on harmine pharmacology?

Yalçın and Bayraktar (2009, 23 citations) on COMT inhibition; Lamchouri (2014, 14 citations) on antitumor properties and toxicity.

What open problems exist in harmine research?

Optimizing bioavailability to reduce toxicity while enhancing kinase inhibition specificity; validating mechanisms in clinical models (Tsuchiya, 2015; Lawson et al., 2016).